China Medical University, China

This early-stage trial tests a new approach for people with colorectal cancer that has spread to the liver and hasn't responded to standard treatments. It combines a virus designed to attack cancer cells (BioTTT001) with two drugs (toripalimab and regorafenib). The study will enr…

This phase 2 trial tests a four-drug maintenance therapy for people with extensive small cell lung cancer that has responded to initial treatment. The combination includes liposome irinotecan, platinum chemotherapy, an immune checkpoint inhibitor (toripalimab), and an anti-angiog…

This study tests a combination of two drugs, sacituzumab tirumotecan and anlotinib, in 30 people with extensive-stage small cell lung cancer whose disease got worse after initial chemotherapy plus immunotherapy. The goal is to see if the combo can shrink tumors or slow cancer gro…

This study tests a group-based program for older adults who feel their memory is slipping but still live independently. The program includes social activities, brain games, physical exercise, healthy eating tips, and ways to manage emotions and health risks. Researchers will meas…